The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
According to deal terms announced Monday, New York-based Ovid will pay AstraZeneca $12.5 million up front, breaking down to $5 million in cash $7.5 million in shares of publicly traded Ovid. Milestone ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Ovid, N.Y. — In the wake of last week's massive fire that tore through the village of Ovid, the community continues to band together to support those affected. The fire, which broke out Tuesday night ...
Barbara Weiden Boyd is a big fan of Ovid, the Latin poet who died just about two thousand years ago. Apart from being a great humorist, she said, Ovid should be applauded for his brilliant re-working ...
Ovid Therapeutics (NASDAQ:OVID) added ~13% on Thursday after Wedbush revised its rating to Outperform from not rated, citing the neuro drug developer’s lead candidate OV329 targeted at rare and ...
Ovid stock surged 18% following positive Phase 1 data for OV329, and investors are getting excited about a forthcoming Phase 2. The company defines OV329 as a "next-generation GABA-aminotransferase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results